Cargando…
Oral Peroxisome Proliferator–Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes
Diabetic corneal neuropathy (DCN) is a common complication of diabetes. However, there are very limited therapeutic options. We investigated the effects of a peroxisome proliferator–activated receptor-α (PPAR-α) agonist, fenofibrate, on 30 patients (60 eyes) with type 2 diabetes. On in vivo confocal...
Autores principales: | Teo, Calesta Hui Yi, Lin, Molly Tzu-Yu, Lee, Isabelle Xin Yu, Koh, Siew-Kwan, Zhou, Lei, Goh, Dylan Shaoying, Choi, Hyungwon, Koh, Hiromi Wai Ling, Lam, Amanda Yun Rui, Lim, Paik Shia, Mehta, Jodhbir S., Kovalik, Jean-Paul, Coffman, Thomas M., Tan, Hong Chang, Liu, Yu-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281232/ https://www.ncbi.nlm.nih.gov/pubmed/36445944 http://dx.doi.org/10.2337/db22-0611 |
Ejemplares similares
-
Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
por: Matsushita, Yuichi, et al.
Publicado: (2011) -
Catalase Deficiency Accelerates Diabetic Renal Injury Through Peroxisomal Dysfunction
por: Hwang, Inah, et al.
Publicado: (2012) -
Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis
por: Caglayan, Evren, et al.
Publicado: (2008) -
Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes
por: Matlock, H. Greg, et al.
Publicado: (2020) -
Genome-Wide Transcriptional Analysis of Differentially Expressed Genes in Diabetic, Healing Corneal Epithelial Cells: Hyperglycemia-Suppressed TGFβ3 Expression Contributes to the Delay of Epithelial Wound Healing in Diabetic Corneas
por: Bettahi, Ilham, et al.
Publicado: (2014)